St Olavs Hospital
Trondheim, Norway
NCT Number: NCT03064750
The lifetime risk for a woman to undergo surgery for either vaginal prolapse or urinary incontinence is high. There are many different surgical techniques for treatment of prolapse, but there is a lack of knowledge about factors that contribute to objective result and patient satisfaction after surgery.
The aim of the study is to investigate factors that could be related to patient satisfaction and objective result such as pelvic floor muscle contractility/strength and muscle injury, objective measures of prolapse and women's symptoms. This study will investigate whether systematic pelvic floor exercise and life style advise before surgery can improve outcomes after surgery for either vaginal prolapse. Another aim is to determine an ultrasound scale for measure of pelvic floor muscle contraction.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Trondheim, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In preparation for surgery, patients receive individual information by a physiotherapist on pelvic floor anatomy and correct pelvic floor contraction. Patients are told to do the following pelvic floor exercises 3 times a day: 8-12 maximal contractions, hold contractions during 10 seconds, and 3 fast contractions after each long contraction. In addition exercise in groups with skilled physical therapists once a week during 12 weeks.
patients wait as usual until surgery without special treatment.
Time frame: 9 months
Muscle strength is evaluated using 6 point modified Oxford Scale (MOS) range 0-5.
Time frame: 9 months
Changes in pelvic floor muscle at rest and during pelvic floor contraction, measured in mm and calculated proportional change
Time frame: 9 months
Symptoms of pelvic floor disorders assessed by validated questionnaire (PDFI-20)
Time frame: 9 months
measuring the pressure with vaginal manometry in cm H2O during pelvic floor contraction
Time frame: 9 months
Assessed by vaginal surface electrode during pelvic floor contraction, measured in mV
Time frame: 9 months
Assessment with the Pelvic Organ Prolapse Quantification (POP-Q) System
Time frame: 9 months
Anatomical sphincter ani defect assessed by transperineal ultrasound
Time frame: 9 months
Assessed by transperineal ultrasound on contraction and Valsalva
Time frame: 9 months
Movement of the pelvic organs during Valsalva and contraction
Time frame: 9 months
Registration of implants after pelvic floor surgery and their relations to anatomical structures in mm.
Time frame: 9 months
Symptoms of pelvic floor disorders assessed by validated questionnaire (PFIQ-7)
Time frame: 9 months
Symptoms of pelvic floor disorders assessed by visual analogue scale (VAS 1-10)
St. Olavs Hospital
Other
Acronym: CONTRAPOP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05440539
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Houston, Texas, United States
View Trial DetailsNCT04415710
Constipation, Female Urogenital Diseases
Antalya, Turkey, Turkey (Türkiye)
View Trial DetailsNCT04198714
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Cleveland, Ohio, United States
View Trial DetailsNCT02431897
Cystocele, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial Details